Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Cash & Current Investments (2016 - 2026)

Biomerica's Cash & Current Investments history spans 17 years, with the latest figure at $1.3 million for Q1 2026.

  • On a quarterly basis, Cash & Current Investments fell 56.31% to $1.3 million in Q1 2026 year-over-year; TTM through Feb 2026 was $1.3 million, a 56.31% decrease, with the full-year FY2025 number at $3.1 million, down 26.67% from a year prior.
  • Cash & Current Investments hit $1.3 million in Q1 2026 for Biomerica, down from $2.5 million in the prior quarter.
  • Over the last five years, Cash & Current Investments for BMRA hit a ceiling of $10.2 million in Q1 2022 and a floor of $1.3 million in Q1 2026.
  • Historically, Cash & Current Investments has averaged $4.9 million across 5 years, with a median of $4.2 million in 2024.
  • Biggest five-year swings in Cash & Current Investments: skyrocketed 92.96% in 2022 and later crashed 67.12% in 2023.
  • Tracing BMRA's Cash & Current Investments over 5 years: stood at $5.1 million in 2022, then surged by 40.81% to $7.1 million in 2023, then crashed by 66.75% to $2.4 million in 2024, then increased by 7.21% to $2.5 million in 2025, then crashed by 47.46% to $1.3 million in 2026.
  • Business Quant data shows Cash & Current Investments for BMRA at $1.3 million in Q1 2026, $2.5 million in Q4 2025, and $3.1 million in Q3 2025.